Sunshine Biopharma Inc

(SBFM)

By |

Profile

Sunshine Biopharma Inc is a pharmaceutical company operating in Canada. It focuses on the research, development, and commercialization of proprietary drugs for the treatment of various forms of cancer. The key product of the company is Adva-27a, a small molecule that destroys multidrug resistant cancer cells, including pancreatic cancer cells, small-cell lung cancer cells, breast cancer cells and uterine sarcoma cells. The company also sells several prescription generic drugs under its own brand SBI such as SBI-Anastrozole for treatment of Breast Cancer, SBI-Letrozole for treatment of Breast Cancer, SBI-Bicalutamide for treatment of Prostate Cancer and SBI-Finasteride for treatment of benign prostatic hyperplasia.

Contact Information

Website: www.sunshinebiopharma.com
Main Phone: +1 514 426-6161
Address: 6500 Trans-Canada Highway
Address 2: 4th Floor
State: QC
City / Town: Pointe-Claire
Country: CAN
Postal Code: H9R 0A5

Issuer Information

Exchange: OTO
CEO: Steve Slilaty
Employees: 12
NAICS: Pharmaceutical Preparation Manufacturing(325412)
$ 0.0006 $ 0. (0.00%)
Last Price 0.0006 Change $ 0. Change % 0.00 Tick N/A
Bid N/A Bid Size N/A Ask N/A Ask Size N/A
Open 0.0005 High 0.0006 Low 0.0005 Prev Close 0.0006
Last Trade Volume 8.1 mi 52 Wk Hi 0.0175 52 Wk Low 0.0003
Market Cap 979,789 Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 1,632,980,943.00 EPS (TTM) 0.00 PE Ratio N/A Exchange OTCPK